The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bleeding Disorders-Global Market Insights and Sales Trends 2024
Synopsis
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
The global Bleeding Disorders market size is expected to reach US$ 16780 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Bleeding Disorders in various end use industries. The expanding demands from the Hemophilia A, Hemophilia B and Others,, are propelling Bleeding Disorders market. Plasma-derived Coagulation Factor Concentrates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Coagulation Factor Concentrates segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bleeding Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bleeding Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bleeding Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bleeding Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bleeding Disorders covered in this report include Novo Nordisk, Bayer, Baxter International, Alnylam Pharmaceuticals, Pfizer, Xenetic Biosciences, Bristol-Myers Squibb Company, Sanofi and Janssen Global Services, etc.
The global Bleeding Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Global Bleeding Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bleeding Disorders market, Segment by Type:
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Global Bleeding Disorders market, by Application
Hemophilia A
Hemophilia B
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bleeding Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
The global Bleeding Disorders market size is expected to reach US$ 16780 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Bleeding Disorders in various end use industries. The expanding demands from the Hemophilia A, Hemophilia B and Others,, are propelling Bleeding Disorders market. Plasma-derived Coagulation Factor Concentrates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Coagulation Factor Concentrates segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bleeding Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bleeding Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bleeding Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bleeding Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bleeding Disorders covered in this report include Novo Nordisk, Bayer, Baxter International, Alnylam Pharmaceuticals, Pfizer, Xenetic Biosciences, Bristol-Myers Squibb Company, Sanofi and Janssen Global Services, etc.
The global Bleeding Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Global Bleeding Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bleeding Disorders market, Segment by Type:
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Global Bleeding Disorders market, by Application
Hemophilia A
Hemophilia B
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bleeding Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bleeding Disorders
1.1 Bleeding Disorders Market Overview
1.1.1 Bleeding Disorders Product Scope
1.1.2 Bleeding Disorders Market Status and Outlook
1.2 Global Bleeding Disorders Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bleeding Disorders Market Size by Region (2018-2029)
1.4 Global Bleeding Disorders Historic Market Size by Region (2018-2023)
1.5 Global Bleeding Disorders Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bleeding Disorders Market Size (2018-2029)
1.6.1 North America Bleeding Disorders Market Size (2018-2029)
1.6.2 Europe Bleeding Disorders Market Size (2018-2029)
1.6.3 Asia-Pacific Bleeding Disorders Market Size (2018-2029)
1.6.4 Latin America Bleeding Disorders Market Size (2018-2029)
1.6.5 Middle East & Africa Bleeding Disorders Market Size (2018-2029)
2 Bleeding Disorders Market by Type
2.1 Introduction
2.1.1 Plasma-derived Coagulation Factor Concentrates
2.1.2 Recombinant Coagulation Factor Concentrates
2.1.3 Desmopressin
2.1.4 Antifibrinolytics
2.1.5 Fibrin Sealants
2.1.6 Others
2.2 Global Bleeding Disorders Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bleeding Disorders Historic Market Size by Type (2018-2023)
2.2.2 Global Bleeding Disorders Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bleeding Disorders Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bleeding Disorders Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bleeding Disorders Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bleeding Disorders Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bleeding Disorders Revenue Breakdown by Type (2018-2029)
3 Bleeding Disorders Market Overview by Application
3.1 Introduction
3.1.1 Hemophilia A
3.1.2 Hemophilia B
3.1.3 Others
3.2 Global Bleeding Disorders Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bleeding Disorders Historic Market Size by Application (2018-2023)
3.2.2 Global Bleeding Disorders Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bleeding Disorders Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bleeding Disorders Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bleeding Disorders Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bleeding Disorders Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bleeding Disorders Revenue Breakdown by Application (2018-2029)
4 Bleeding Disorders Competition Analysis by Players
4.1 Global Bleeding Disorders Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bleeding Disorders as of 2022)
4.3 Date of Key Players Enter into Bleeding Disorders Market
4.4 Global Top Players Bleeding Disorders Headquarters and Area Served
4.5 Key Players Bleeding Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Bleeding Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novo Nordisk
5.1.1 Novo Nordisk Profile
5.1.2 Novo Nordisk Main Business
5.1.3 Novo Nordisk Bleeding Disorders Products, Services and Solutions
5.1.4 Novo Nordisk Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.1.5 Novo Nordisk Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Bleeding Disorders Products, Services and Solutions
5.2.4 Bayer Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Baxter International
5.3.1 Baxter International Profile
5.3.2 Baxter International Main Business
5.3.3 Baxter International Bleeding Disorders Products, Services and Solutions
5.3.4 Baxter International Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.3.5 Alnylam Pharmaceuticals Recent Developments
5.4 Alnylam Pharmaceuticals
5.4.1 Alnylam Pharmaceuticals Profile
5.4.2 Alnylam Pharmaceuticals Main Business
5.4.3 Alnylam Pharmaceuticals Bleeding Disorders Products, Services and Solutions
5.4.4 Alnylam Pharmaceuticals Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.4.5 Alnylam Pharmaceuticals Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Bleeding Disorders Products, Services and Solutions
5.5.4 Pfizer Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Xenetic Biosciences
5.6.1 Xenetic Biosciences Profile
5.6.2 Xenetic Biosciences Main Business
5.6.3 Xenetic Biosciences Bleeding Disorders Products, Services and Solutions
5.6.4 Xenetic Biosciences Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.6.5 Xenetic Biosciences Recent Developments
5.7 Bristol-Myers Squibb Company
5.7.1 Bristol-Myers Squibb Company Profile
5.7.2 Bristol-Myers Squibb Company Main Business
5.7.3 Bristol-Myers Squibb Company Bleeding Disorders Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Company Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Company Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Bleeding Disorders Products, Services and Solutions
5.8.4 Sanofi Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Janssen Global Services
5.9.1 Janssen Global Services Profile
5.9.2 Janssen Global Services Main Business
5.9.3 Janssen Global Services Bleeding Disorders Products, Services and Solutions
5.9.4 Janssen Global Services Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.9.5 Janssen Global Services Recent Developments
5.10 Bioverativ
5.10.1 Bioverativ Profile
5.10.2 Bioverativ Main Business
5.10.3 Bioverativ Bleeding Disorders Products, Services and Solutions
5.10.4 Bioverativ Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.10.5 Bioverativ Recent Developments
5.11 Amgen
5.11.1 Amgen Profile
5.11.2 Amgen Main Business
5.11.3 Amgen Bleeding Disorders Products, Services and Solutions
5.11.4 Amgen Bleeding Disorders Revenue (US$ Million) & (2018-2023)
5.11.5 Amgen Recent Developments
6 North America
6.1 North America Bleeding Disorders Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bleeding Disorders Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bleeding Disorders Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bleeding Disorders Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bleeding Disorders Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bleeding Disorders Market Dynamics
11.1 Bleeding Disorders Industry Trends
11.2 Bleeding Disorders Market Drivers
11.3 Bleeding Disorders Market Challenges
11.4 Bleeding Disorders Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
